/Heart%20rate%20monitor%20during%20surgery%20operation%20by%20bilanol%20via%20Adobe%20Stock.jpeg)
Due to Baxter International's underperformance relative to the S&P 500 over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.
Baxter International (BAX) shares are attempting a technical turnaround, breaking a multi-week downtrend that increasingly appears to have bottomed around $16. The stock currently carries an 8% “Sell”...
1 Stock Under $50 Worth Investigating and 2 Facing Challenges
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
1 Unprofitable Stock to Keep an Eye On and 2 We Ignore
Baxter International (NYSE:BAX) held its 2026 annual meeting of stockholders by webcast, with shareholders giving preliminary approval to all five proposals presented by the company, including the election...
5 Revealing Analyst Questions From Baxter’s Q1 Earnings Call
/Baxter%20International%20Inc_%20logo%20and%20chart-by%20IgorGolovniov%20via%20Shutterstock.jpg)
As Baxter International has notably underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.